Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Focus on Canine Cancer – Media Education Session

Thursday, January 25, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Volition's Media Education Session focused on canine cancer, featuring insights from veterinary oncologists. The session covered the importance of cancer screening and introduced the Nu.Q® Vet cancer test, which is being developed for both dogs and cats. This initiative aims to enhance awareness and provide valuable resources for veterinarians and pet owners.
Price reaction · baseline $22 (2024-01-24 close) · hit pre-market · 5 other VNRX headline(s) in the window, move may be shared
day 0 close
-5.5%
day 1
-2.7%
day 3 · peak
-8.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Educational session highlights canine cancer awareness.
  • Expert insights from leading veterinary oncologists.
  • Introduction of innovative cancer screening methods.

Full Press Release Details

Media Education Session, featuring Volition CMO, Heather Wilson-Robles, DVM, DACVIM (Oncology), Dr. Sue Ettinger, DVM, DACVIM (Oncology), and Dr. Lisa Lippman, DVM
Watch our video for:
• Canine Cancer overview
• Cancer Screening: its importance
• On overview of nucleosomes and why we measure them?
• Case studies of Nu.Q ® Vet
• Tips for vets and pet owners

Related Articles

• Press Releases Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment
• Press Releases Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment

Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What was the focus of the Media Education Session?

The session focused on canine cancer, covering screening importance and expert insights.

Who were the speakers at the session?

The session featured Dr. Heather Wilson-Robles, Dr. Sue Ettinger, and Dr. Lisa Lippman.

What is the Nu.Q® Vet cancer test?

Nu.Q® Vet is a cancer screening test designed for both dogs and cats.

What topics were discussed during the session?

Topics included canine cancer overview, screening importance, and case studies.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare canine cancer Nu.Q Vet cancer screening Volition veterinary oncology
Last updated: Jan 25, 2024

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk